iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
132.65
-0.31 (-0.23%)
At close: Jan 17, 2025, 4:00 PM
132.56
-0.09 (-0.07%)
After-hours: Jan 17, 2025, 5:04 PM EST
IBB Holdings List
As of Jan 17, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 8.51% |
2 | AMGN | Amgen Inc. | 8.25% |
3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.73% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.28% |
5 | IQV | IQVIA Holdings Inc. | 3.58% |
6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.18% |
7 | ARGX | argenx SE | 3.03% |
8 | MTD | Mettler-Toledo International Inc. | 2.71% |
9 | WAT | Waters Corporation | 2.42% |
10 | ILMN | Illumina, Inc. | 2.17% |
11 | BNTX | BioNTech SE | 2.11% |
12 | BIIB | Biogen Inc. | 2.05% |
13 | NTRA | Natera, Inc. | 1.98% |
14 | UTHR | United Therapeutics Corporation | 1.59% |
15 | NBIX | Neurocrine Biosciences, Inc. | 1.42% |
16 | INCY | Incyte Corporation | 1.37% |
17 | ONC | BeiGene, Ltd. | 1.31% |
18 | INSM | Insmed Incorporated | 1.27% |
19 | ITCI | Intra-Cellular Therapies, Inc. | 1.26% |
20 | TECH | Bio-Techne Corporation | 1.20% |
21 | MRNA | Moderna, Inc. | 1.18% |
22 | BMRN | BioMarin Pharmaceutical Inc. | 1.17% |
23 | GMAB | Genmab A/S | 1.09% |
24 | SRPT | Sarepta Therapeutics, Inc. | 1.06% |
25 | PCVX | Vaxcyte, Inc. | 1.03% |
26 | EXEL | Exelixis, Inc. | 1.02% |
27 | MEDP | Medpace Holdings, Inc. | 0.87% |
28 | RGEN | Repligen Corporation | 0.84% |
29 | CRL | Charles River Laboratories International, Inc. | 0.83% |
30 | HALO | Halozyme Therapeutics, Inc. | 0.70% |
31 | BPMC | Blueprint Medicines Corporation | 0.68% |
32 | ASND | Ascendis Pharma A/S | 0.61% |
33 | BRKR | Bruker Corporation | 0.59% |
34 | RVMD | Revolution Medicines, Inc. | 0.57% |
35 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.54% |
36 | CYTK | Cytokinetics, Incorporated | 0.52% |
37 | BBIO | BridgeBio Pharma, Inc. | 0.50% |
38 | LEGN | Legend Biotech Corporation | 0.47% |
39 | ALKS | Alkermes plc | 0.47% |
40 | IONS | Ionis Pharmaceuticals, Inc. | 0.46% |
41 | ROIV | Roivant Sciences Ltd. | 0.42% |
42 | ADMA | ADMA Biologics, Inc. | 0.37% |
43 | AXSM | Axsome Therapeutics, Inc. | 0.37% |
44 | KRYS | Krystal Biotech, Inc. | 0.36% |
45 | RARE | Ultragenyx Pharmaceutical Inc. | 0.34% |
46 | BHVN | Biohaven Ltd. | 0.34% |
47 | CRSP | CRISPR Therapeutics AG | 0.33% |
48 | PTCT | PTC Therapeutics, Inc. | 0.33% |
49 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.33% |
50 | NUVL | Nuvalent, Inc. | 0.32% |
As of Jan 17, 2025